ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2682

Correlation between Capillaroscopic Patterns of Nailfold Microangiopathy and Three Different Methods to Assess Dermal Thickness in Systemic Sclerosis Patients

Barbara Ruaro1, Alberto Sulli2, Carmen Pizzorni1, Elisa Alessandri1, Sabrina Paolino1, Massimo Ghio1, Veronica Tomatis3, Vanessa Smith4 and Maurizio Cutolo1, 1Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino, Genoa, Italy, Genoa, Italy, 2Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS San Martino, Genoa, Italy, Genova, Italy, 3Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, Genoa, Italy, 4Department of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium, Ghent, Belgium

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, skin, Systemic sclerosis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is characterized by increase of dermal thickness (DT) and impairment of microvascular system (1). Several studies demonstrate that nailfold capillaroscopy (NVC) patterns of microangiopathy correlate with organ involvement, but few studies investigated the correlation between nailfold microangiopathy and skin involvement. The modified Rodnan skin score (mRss) is the validated method to assess the severity of skin damage (2,3), high frequency skin ultrasound (US) is able to detect skin damage in SSc (4,5), and the plicometer skin test (Plicometry) is a further method to evaluate cutaneous involvement in SSc patients (6). The aim of this study was to identify possible correlations between different patterns of nailfold microangiopathy and three different methods (mRss, US and Plicometry) to assess DT in SSc patients.

Methods: Sixty-three SSc patients (ACR/EULAR criteria) (mean age 64±11SD years, mean disease duration 7±6 years, 43 lcSSc and 20 dcSSc) and 63 sex and age matched healthy subjects were enrolled, after written informed consent. All subjects were assessed by mRss, US and Plicometry to evaluate DT in the seventeen skin areas of the body usually evaluated by mRss (zygoma, fingers, dorsum of hands, forearms, upper arms, chest, abdomen, thighs, legs, feet) (1-6). NVC was performed to assess the proper pattern of microangiopathy (“Early”, “Active” or “Late” pattern) and to calculate the microangiopathy evolution score (MES) (7-8). Statistical evaluation was performed by non-parametric tests.

Results: There was a statistically significant positive correlation between DT values and severity of nailfold microangiopathy: all methods detected a progressively higher DT in patients with “Early”, “Active” and “Late” pattern of microangiopathy (p<0.005), and a positive correlation was observed also with MES (r=0.71 p<0.001). Finally, a positive correlation was observed in SSc patients between the three method to evaluate DT (Plicometry vs mRss r=0.98, p<0.0001; Plicometry vs US r=0.53, p<0.0001; US vs mRss r=0.53, p<0.0001). As expected, the group of SSc patients had a statistically significant higher DT at level of all areas, as evaluated by the three methods, when compared to the control group (p<0.0001).

Conclusion: This study demonstrates a relationship between skin damage and microangiopathy impairment in SSc patients, as well as a correlation between different methods to assess DT.

References. 1. Moore TL, et al. Rheumatology 2003;42:1559-63. 2. Sulli A, et al. Ann Rheum Dis. 2014;69:1140-3. 3. Kaldas M, et al. Rheumatology 2009;48:1143-6. 4. Hesselstrand R, et al. Rheumatology 2008;47:84-7. 5. Kaloudi O, et al. Ann Rheum Dis.2010;69:1140-3. 6. Parodi MN, et al. Br JRheumatol. 1997;36:244-50. 7. Sulli A, et al. Ann Rheum Dis 2008;67:885-7. 8. Cutolo et al. J Rheumatol 2000; 27;155.60.


Disclosure: B. Ruaro, None; A. Sulli, None; C. Pizzorni, None; E. Alessandri, None; S. Paolino, None; M. Ghio, None; V. Tomatis, None; V. Smith, None; M. Cutolo, None.

To cite this abstract in AMA style:

Ruaro B, Sulli A, Pizzorni C, Alessandri E, Paolino S, Ghio M, Tomatis V, Smith V, Cutolo M. Correlation between Capillaroscopic Patterns of Nailfold Microangiopathy and Three Different Methods to Assess Dermal Thickness in Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/correlation-between-capillaroscopic-patterns-of-nailfold-microangiopathy-and-three-different-methods-to-assess-dermal-thickness-in-systemic-sclerosis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-between-capillaroscopic-patterns-of-nailfold-microangiopathy-and-three-different-methods-to-assess-dermal-thickness-in-systemic-sclerosis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology